Physician Profile
Based in Boston, MA, Maria Beatrice T. Alora, MD is listed in the NPI registry under dermatology. According to Medicare claims data, Maria Beatrice cared for 340 Medicare patients across 484 services. The services billed most often include destruction of precancer skin growth, 2-14 growths, aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg), and application of light to destroy precancer skin growth. NPI 1093841850 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET
Boston, MA 02114
Within Dermatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Acne and follicular disorders
Eczema and inflammatory skin disease
Infections and infestations
Pigment, growths, and benign lesions
Skin cancer
Urticaria, itch, and vascular
Autoimmune and connective tissue
Infections
Rashes & allergy
Skin growths
Most searched procedures
Diagnostic procedures
Lesion treatment
Medical dermatology treatment
Cosmetic
Cosmetic and minor surgery
Cosmetic dermatology
Diagnostic
General dermatology
Infections
Medical dermatology
Nails & hair
Skin cancer surgery
Skin growths
484 services · 340 patients · 7 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | Procedure | 17003 |
141 | Less often than most peers in Dermatology |
| Destruction of precancer skin growth, 1 growth | Procedure | 17000 |
56 | Less often than most peers in Dermatology |
| Application of light to destroy precancer skin growth | Treatment | 96567 |
74 | More often than most peers in Dermatology |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Drug given | J7308 |
74 | More often than most peers in Dermatology |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | Office visit | 99213 |
71 | Less often than most peers in Dermatology |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Office visit | 99214 |
55 | Less often than most peers in Dermatology |
| New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | Office visit | 99203 |
13 | Less often than most peers in Dermatology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Dr. Alora is a dermatologist (skin doctor) in Boston, MA. That is the designation recorded for this NPI in the federal registry, where it is listed as “Dermatology”.
NPI registry
Dr. Alora is listed at Massachusetts General Hospital 55 Fruit Street, Boston, MA 02114. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (617) 726-1660. Contact the office directly to confirm availability and scheduling.
NPI registry
Dr. Alora's National Provider Identifier is 1093841850. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Dr. Alora attended Other, graduating in 1990. This comes from the CMS National Downloadable File.
CMS public data
Dr. Alora has 36 years experience. Calculated from a graduation year of 1990, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Dr. Alora performs procedures including destruction of precancer skin growth, 2-14 growths and destruction of precancer skin growth, 1 growth; provides treatments such as application of light to destroy precancer skin growth, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Alora. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.